Issue 3/2022
Content (11 Articles)
Reirradiation of Recurrent and Second Primary Cancers of the Head and Neck: a Review of the Contemporary Evidence
Paul J. Kreinbrink, Luke M. Lewis, Kevin P. Redmond, Vinita Takiar
Pathogenesis and Amelioration of Radiation-Induced Oral Mucositis
Charles T. Lee, Thomas J. Galloway
HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?
James E. Bates, Conor E. Steuer
Cancer Therapies and Vascular Toxicities
Alexandra Meilhac, Jennifer Cautela, Franck Thuny
Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer
Nicole Bates, Jennifer K. Bello, Nosayaba Osazuwa-Peters, Mark D. Sullivan, Jeffrey F. Scherrer
Which FLT3 Inhibitor for Treatment of AML?
Jayastu Senapati, Tapan Mahendra Kadia
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)
Yaya Chu, Margaret Lamb, Mitchell S. Cairo, Dean A. Lee
Role of Virus-Directed Therapy in Soft Tissue Sarcoma
Hira Chaudhary, Sandra D’Angelo
Immunotherapy and Biomarkers in Sarcoma
Thanate Dajsakdipon, Teerada Siripoon, Nuttapong Ngamphaiboon, Touch Ativitavas, Thitiya Dejthevaporn
What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?
Bernd Kasper, Lorenzo D’Ambrosio, Elizabeth J. Davis, Matthew Ingham, Javier Martin Broto, Jonathan C. Trent, Winan J. van Houdt, Brian A. Van Tine
Correction to: Cancer-Related Fatigue: Causes and Current Treatment Options
Melissa S.Y. Thong, Cornelis J. F. van Noorden, Karen Steindorf, Volker Arndt